Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Building Tough Connections: Individual Bits of knowledge on Association - 2November Lease Deals for the 2025 Kia EV6 are Too Good to Pass Up
- 3Scientists are getting our robotic explorers ready to help send humans to Mars
- 4What's A Decent FICO rating?
- 5SpaceX launches Starlink satellites on its 150th Falcon 9 mission of the year
- NASA unveils close-up pictures of the comet popping by from another star
- Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
- Father and son spending Christmas together after health scares
- The Significance of Health Projects in Senior Protection.
- Who plays Moana in the live-action remake? What to know about Catherine Lagaʻaia.
- 37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- Instructions to Pick the Right Dental Embed Trained professional: An Exhaustive Aide
- The most effective method to Go with Informed Choices on Vehicle Leases
- French lawmakers narrowly approve health care budget, suspending Macron's flagship pension reform
